Combined therapy with infliximab and seton drainage for perianal fistulizing Crohn’s disease with anal endosonographic monitoring: a single-centre experience
- 10 June 2008
- journal article
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 12 (2) , 111-117
Abstract
During infliximab treatment of perianal Crohn’s disease (CD), the healing of the skin opening precedes fistula tract healing and this contributes to abscess formation and fistula recurrence. The aims of this study were to evaluate the efficacy of combined treatment with infliximab and setons for complex perianal fistulas in CD and to define the optimal time for seton removal by anal endosonography (AE). Nine consecutive patients with CD were studied. Perianal sepsis was eradicated when necessary and setons were placed before infliximab therapy. Setons were removed after AE evidence of fistulous tracts healing. Patients received a mean of 10±2.3 infliximab infusions. At week 6 all patients showed a reduction in mean CD activity index (pp<0.0001). Complete fistula response was achieved in eight of nine patients. In six patients after a mean of 9.2 infusions, infliximab treatment was discontinued. Clinical and AE response persisted at 19.4±8.8 months (range 3–28 months) in five of these patients. One patient had fistula recurrence 20 weeks after infliximab discontinuation and responded rapidly to retreatment. At the time of this report, two patients were still on infliximab and in remission after a mean follow-up of 25±5 months. Combined therapy with infliximab and setons with AE monitoring of the response showed high efficacy in the management of patients with CD with complex perianal fistulas.Keywords
This publication has 34 references indexed in Scilit:
- Fistulating Anal Crohn's Disease: Results of Combined Surgical and Infliximab TreatmentDiseases of the Colon & Rectum, 2006
- Local Injection of Infliximab for the Treatment of Perianal Crohn's DiseaseDiseases of the Colon & Rectum, 2005
- Anti-TNF-α (Infliximab) Used as Induction Treatment in Case of Active Proctitis in a Multistep Strategy Followed by Definitive Surgery of Complex Anal Fistulas in Crohn's Disease: A Preliminary ReportDiseases of the Colon & Rectum, 2005
- Infliximab in the surgical management of complex fistulating anal Crohn's diseaseColorectal Disease, 2005
- Infliximab Maintenance Therapy for Fistulizing Crohn's DiseaseNew England Journal of Medicine, 2004
- Combining infliximab and methotrexate in fistulizing Crohn's disease resistant or intolerant to azathioprineAlimentary Pharmacology & Therapeutics, 2004
- Combined Seton Placement, Infliximab Infusion, and Maintenance Immunosuppressives Improve Healing Rate in Fistulizing Anorectal Crohn's DiseaseDiseases of the Colon & Rectum, 2003
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- Usual Therapy Improves Perianal Crohn??s Disease as Measured by a New Disease Activity IndexJournal of Clinical Gastroenterology, 1995
- A classification of fistula-in-anoBritish Journal of Surgery, 1976